- All Courts
- Federal Courts
- Bankruptcies
- PTAB
- ITC
Filters
Like full text docket searches?
Get docket alerts, perform legal research, get updates of major decisions and orders, use our advanced analytics, and more. Request a Demo or create your account.
Date Filed
Dollars
Find cases based on dollar amount with searches like:
$100k-$10M.
Read the details here.
Displaying 129-143 of
165 results
1025 Exhibit: EX1025 van der Bijl
Document
IPR2018-00173, No. 1025 Exhibit - EX1025 van der Bijl (P.T.A.B. Dec. 4, 2017)
|
|
Cite Document
2016 Exhibit: US Patent No 8,029,820
Document
IPR2018-00173, No. 2016 Exhibit - US Patent No 8,029,820 (P.T.A.B. Mar. 13, 2018)
|
|
Cite Document
2018 Exhibit: R Hinz et al, In vitro percutaneous penetration evaluation of the utility...
Document
IPR2018-00173, No. 2018 Exhibit - R Hinz et al, In vitro percutaneous penetration evaluation of the utility of hairless mouse skin (P.T.A.B. Mar. 13, 2018)
|
|
Cite Document
1033 Exhibit: EX1033 US Patent No 6,024,976 to Miranda
Document
IPR2018-00173, No. 1033 Exhibit - EX1033 US Patent No 6,024,976 to Miranda (P.T.A.B. Dec. 4, 2017)
|
|
Cite Document
1036 Exhibit: EX1036 US 9,730,900 to Mantelle
Document
IPR2018-00173, No. 1036 Exhibit - EX1036 US 9,730,900 to Mantelle (P.T.A.B. Dec. 4, 2017)
|
|
Cite Document
1035 Exhibit: EX1035 US 9,730,900 File History Part 2 of 2
Document
IPR2018-00173, No. 1035-2 Exhibit - EX1035 US 9,730,900 File History Part 2 of 2 (P.T.A.B. Dec. 4, 2017)
|
|
Cite Document
2013 Exhibit: K Walters K Brain, Dermatological Formulation and Transdermal Syst...
Document
IPR2018-00173, No. 2013 Exhibit - K Walters K Brain, Dermatological Formulation and Transdermal Systems (P.T.A.B. Mar. 13, 2018)
|
|
Cite Document
2005 Exhibit: J Hadgraft, Passive enhancement strategies in topical and transderm...
Document
IPR2018-00173, No. 2005 Exhibit - J Hadgraft, Passive enhancement strategies in topical and transdermal drug delivery (P.T.A.B. Mar. 13, 2018)
|
|
Cite Document
1023 Exhibit: EX1023 Dinger Noven Pharmaceuticals, Inc
Document
IPR2018-00173, No. 1023 Exhibit - EX1023 Dinger Noven Pharmaceuticals, Inc (P.T.A.B. Dec. 4, 2017)
|
|
Cite Document
2021 Exhibit: R Subedi et al, Formulation and in vitro evaluation of transdermal dru...
Document
IPR2018-00173, No. 2021 Exhibit - R Subedi et al, Formulation and in vitro evaluation of transdermal drug delivery system for donezil (P.T.A.B. Mar. 13, 2018)
|
|
Cite Document
2020 Exhibit: R Subedi et al, Influence of formulation variable in transdermal drug d...
Document
IPR2018-00173, No. 2020 Exhibit - R Subedi et al, Influence of formulation variable in transdermal drug delivery system containing zolmitriptan (P.T.A.B. Mar. 13, 2018)
|
|
Cite Document
2011 Exhibit: A Williams B Barry, Chemical Permeation Enhancement
Document
IPR2018-00173, No. 2011 Exhibit - A Williams B Barry, Chemical Permeation Enhancement (P.T.A.B. Mar. 13, 2018)
|
|
Cite Document
2007 Exhibit: A Williams B Barry, Urea analogues in propylene glycol as penetration...
Document
IPR2018-00173, No. 2007 Exhibit - A Williams B Barry, Urea analogues in propylene glycol as penetration enhancers in human skin (P.T.A.B. Mar. 13, 2018)
|
|
Cite Document
1002 Exhibit: EX1002 Declaration of Keith Brain, PhD
Document
IPR2018-00173, No. 1002 Exhibit - EX1002 Declaration of Keith Brain, PhD (P.T.A.B. Dec. 4, 2017)
|
|
Cite Document
2019 Exhibit: J Bond B Barry, Hairless mouse skin is limited as a model for assessin...
Document
IPR2018-00173, No. 2019 Exhibit - J Bond B Barry, Hairless mouse skin is limited as a model for assessing the effects of penetration enhancers in human skin (P.T.A.B. Mar. 13, 2018)
|
|
Cite Document
